Genetic Architecture of Circulating Very-Long-Chain (C24:0 and C22:0) Ceramide Concentrations
Journal of Lipid and Atherosclerosis · 2020 · 9 (1) · 172
DOI: 10.12997/jla.2020.9.1.172 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Lipid and Atherosclerosis, 2020. Verfasst von Sharon Cresci und 8 weiteren Autor:innen. Beteiligte Einrichtung: Diabetic Cardiovascular Disease Center, Cardiovascular Division, Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NHLBI NIH HHS, NIGMS NIH HHS, NIDDK NIH HHS.
Abstract (Originalsprache)
OBJECTIVE: Total ceramide concentrations are linked with increased insulin resistance and cardiac dysfunction. However, recent studies have demonstrated that plasma concentrations of specific very-long-chain fatty ceramides (C24:0 and C22:0) are associated with a reduced incidence of coronary heart disease and all-cause mortality. We hypothesized that specific genetic loci are associated with plasma C22:0 and C24:0 concentrations. METHODS: Heritability and genome-wide association studies of plasma C24:0 and C22:0 ceramide concentrations were performed among 2,217 participants in the Framingham Heart Study Offspring Cohort, adjusting for cardiovascular risk factor covariates and cardiovascular drug treatment. RESULTS: The multivariable-adjusted heritability for C22:0 and C24:0 ceramides was 0.42 (standard error [SE], 0.07; p=1.8E-9) and 0.25 (SE, 0.08; p=0.00025), respectively. Nineteen single nucleotide polymorphisms (SNPs), all on chromosome 20, significantly associated with C22:0 concentrations; the closest gene to these variants was SPTLC3. The lead SNP (rs4814175) significantly associated with 3% lower plasma C22:0 concentrations (p=2.83E-11). Nine SNPs, all on chromosome 20 and close to SPTLC3, were significantly associated with C24:0 ceramide concentrations. All 9 were also significantly related to plasma C22:0 levels. The lead SNP (rs168622) was significantly associated with 10% lower plasma C24:0 ceramide concentrations (p=9.94E-09). CONCLUSION: SNPs near the SPTLC3 gene, which encodes serine palmitoyltransferase long chain base subunit 3 (SPTLC3; part of the enzyme that catalyzes the rate-limiting step of de novo sphingolipid synthesis) were associated with plasma C22:0 and C24:0 ceramide concentrations. These results are biologically plausible and suggest that SPTLC3 may be a potential therapeutic target for C24:0 and C22:0 ceramide modulation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Diabetic Cardiovascular Disease Center, Cardiovascular Division, Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA.
- Department of Biostatistics and Epidemiology, Boston University School of Public Health, Boston, MA, USA.
- Division of Cardiovascular Medicine and Epidemiology, Vanderbilt University Medical Center, Nashville, TN, USA.
- Framingham Heart Study, Framingham, MA, USA.
- Section of Preventive Medicine and Epidemiology, Department of Medicine, Boston University, Boston, MA, USA.
- Section of Cardiology, Department of Medicine, Boston University, Boston, MA, USA.
ORCID-Profile: Sharon Cresci, Qiong Yang, Meredith S Duncan, Vanessa Xanthakis, Xuntian Jiang, Ramachandran S Vasan, Jean E Schaffer, Linda R Peterson
Förderung
- NHLBI NIH HHS
- NIGMS NIH HHS
- NIDDK NIH HHS
- NINR NIH HHS
- National Institutes of Health
- Foundation for Barnes-Jewish Hospital
Zitieren
APA
Cresci, S., Zhang, R., Yang, Q., Duncan, M. S., Xanthakis, V., Jiang, X., Vasan, R. S., Schaffer, J. E., & Peterson, L. R. (2020). Genetic Architecture of Circulating Very-Long-Chain (C24:0 and C22:0) Ceramide Concentrations. Journal of Lipid and Atherosclerosis, 9(1), 172. https://doi.org/10.12997/jla.2020.9.1.172
Vancouver
Cresci S, Zhang R, Yang Q, Duncan MS, Xanthakis V, Jiang X, et al. Genetic Architecture of Circulating Very-Long-Chain (C24:0 and C22:0) Ceramide Concentrations. Journal of Lipid and Atherosclerosis. 2020;9(1):172. doi:10.12997/jla.2020.9.1.172
BibTeX
@article{Cresci2020,
author = {Cresci, Sharon and Zhang, Ruibo and Yang, Qiong and Duncan, Meredith S and Xanthakis, Vanessa and Jiang, Xuntian and Vasan, Ramachandran S and Schaffer, Jean E and Peterson, Linda R},
title = {Genetic Architecture of Circulating Very-Long-Chain (C24:0 and C22:0) Ceramide Concentrations},
journal = {Journal of Lipid and Atherosclerosis},
year = {2020},
volume = {9},
number = {1},
pages = {172},
doi = {10.12997/jla.2020.9.1.172}
}
EUVIMED